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Abstract
Background: The expansion of the obesity epidemic is accompanied with an increase in bariatric procedures,
in particular in women of reproductive age. The weight loss induced by the surgery is believed to reverse the
negative impact of overweight and obesity on female reproduction, however, research is limited to in particular
retrospective cohort studies and a growing number of small case-series and case-(control) studies.
Methods/design: AURORA is a multicenter prospective cohort study. The main objective is to collect long-term
data on reproductive outcomes before and after bariatric surgery and in a subsequent pregnancy. Women aged
18–45 years are invited to participate at 4 possible inclusion moments: 1) before surgery, 2) after surgery, 3) before
15 weeks of pregnancy and 4) in the immediate postpartum period (day 3–4). Depending on the time of inclusion,
data are collected before surgery (T1), 3 weeks and 3, 6, 12 or x months after surgery (T2-T5) and during the first,
second and third trimester of pregnancy (T6-T8), at delivery (T9) and 6 weeks and 6 months after delivery (T10-T11).
Online questionnaires are send on the different measuring moments. Data are collected on contraception, menstrual
cycle, sexuality, intention of becoming pregnant, diet, physical activity, lifestyle, psycho-social characteristics and dietary
supplement intake. Fasting blood samples determine levels of vitamin A, D, E, K, B-1, B-12 and folate, albumin, total
protein, coagulation parameters, magnesium, calcium, zinc and glucose. Participants are weighted every measuring
moment. Fetal ultrasounds and pregnancy course and complications are reported every trimester of pregnancy.
Breastfeeding is recorded and breast milk composition in the postpartum period is studied.
Discussion: AURORA is a multicenter prospective cohort study extensively monitoring women before undergoing
bariatric surgery until a subsequent pregnancy and postpartum period.
Trial registration: Retrospectively registered (July 2015 - NCT02515214)
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Background
Obesity among women aged 20 years or older has become
a global health problem. The World Health Organization
estimated that about 13 % of the world’s adult female
population was obese in 2014 [1]. It is demonstrated that
obesity negatively affects reproduction, illustrated by in-
creased fertility problems by anovulation in women with
polycystic ovary syndrome [2]. A future pregnancy in
these women is accompanied with an increased risk for
gestational diabetes mellitus, (pre)eclampsia, pregnancy
induced hypertension, induction of labor, cesarean section
and more neonates with a birth weight ≥ 4000 g [3, 4]. In
addition, breastfeeding initiation and duration ratios
appear to be lower in obese women [5]. Therefore, the
American College of Obstetrics and Gynecology (ACOG)
advices women to lose weight before conception [6].
Lifestyle modifications are put forward as the first-line
treatment, however, these modifications rarely result in
successful long term weight loss. Nowadays, bariatric
surgery in combination with lifestyle modifications is
considered to be the best treatment to achieve successful
weight loss on the long term in individuals with a BMI ≥
35 kg/m2 with comorbidities or a BMI ≥ 40 kg/m2.
The most commonly performed procedure worldwide
is the Roux-en-Y gastric bypass (RYGB – 45 %) [7]. This
procedure induces a combination of restriction in food
intake and a certain degree of malabsorption. Procedures
that mainly induce a restriction in food intake, such as
sleeve gastrectomie (SG) and laparoscopic adjustable
gastric banding (LAGB), are performed less frequently.
SG was performed in 37 % of the patients and LAGB in
10 % of the patients worldwide in 2013 [8]. Procedures
that mainly intend to induce nutrient malabsorption by
bypassing the gastro-intestinal tract in a complex way,
such as biliopancreatic diversion with or without duo-
denal switch (BPD/DS), are performed rarely (2.2 %) [7].
Bariatric surgery is found to decrease the overall, cardio-
vascular and diabetes related mortality, and implicates
greater improvements in quality of life compared to
non-surgical controls [9–11].
The increasing number of bariatric procedures in female
adolescents and women of reproductive age is a major
challenge for follow-up of pregnancies [12, 13]. Official
organizations recommend delaying pregnancy 12 to
18 months after surgery in order to avoid the period of
rapid weight loss [6]. Small studies comparing the pre-
and post-bariatric surgery fertility status report an
improvement in spontaneous fertility rates [14, 15]. This
improved fertility makes safe and reliable contraception
necessary in order to avoid early pregnancy, however,
evidence on contraceptive safety and effectiveness is
limited [16–18]. Concerns also rise on the potential
impact of bariatric surgery on future pregnancy. Adverse
obesity-related maternal, fetal and neonatal outcomes are
reported less frequent in the bariatric pregnant population
compared to the (morbidly) obese pregnant population,
including the risk for gestational diabetes mellitus, hyper-
tensive disorders in pregnancy, cesarean section, large-for-
gestational age and +4 kg babies [16, 19–21]. A clinical
challenge has risen with the diagnosis of gestational dia-
betes mellitus in pregnant women with previous bariatric
surgery, since Freitas et al. [22] illustrated that almost
60 % of the women develops severe dumping symptoms
by using the standard diagnostic methods for gestational
diabetes (oral glucose tolerance test). Alternative methods,
including home glucose monitoring and the assessment of
hbA1c or fasten glucose levels, might be considered.
Additionally, caution is needed with surgical complica-
tions and nutritional deficiencies in pregnancy, since both
complications have been associated with increased peri-
natal mortality rates, preterm birth, small-for-gestational
age and growth restricted babies and fetal and neonatal
abnormalities [23, 24]. Several cases of severe surgical
complications, including small bowel volvulus, obstruction
and subsequent internal herniation, have been reported
[25]. Recently, the incidence of internal herniation in preg-
nancy following bariatric surgery was estimated on 1 % in
a Danish retrospective register-based cohort study [16, 26].
The nutritional status after bariatric surgery is often
poor, especially in individuals with procedures inducing
malabsorption by bypassing a large part of the small
intestine [27]. In RYGB patients, mechanical digestion
and acid secretion are limited, possibly leading to an
impaired digestion and absorption of certain micronutri-
ents (e.g. iron and vitamin B-12) and a reduction in the
secretion of intrinsic factor (further complicating the
absorption of certain micronutrients). Deficiencies can
also be caused by insufficient intake of nutrients, food
intolerance and excessive nausea and vomiting [27]. The
combination of a bariatric procedure and the physio-
logical changes during pregnancy theoretically increases
the risk for nutritional deficiencies. Several case-reports
and small cohort studies have been published on adverse
maternal, fetal and neonatal outcomes after vit K1, vit
B-12, vit A, folate and iron deficiencies [16, 28, 29]. These
nutritional deficiencies, combined with poor eating habits
in pregnant women with bariatric surgery [30], can affect
the nutritional value of breast milk. Case reports have
been published of clinical vitamin B-12 deficiencies
in newborns receiving exclusively breastfeeding from
vit B-12 deficient mothers with a history of bariatric
surgery [31–33].
Need for more research?
The current evidence on reproduction outcomes after
bariatric surgery is mainly based on retrospective cohort
studies, and a growing number of small case(-control)
series. A control group is frequently missing and often
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varies between studies [16]. Data from large prospective
cohort studies, starting before surgery and continuing till
a subsequent pregnancy, would be beneficial to obtain
insight on reproductive issues following bariatric surgery
and to optimize the health care of this specific population.
As a result, main knowledge gaps in the field are related
to 1) effective contraceptive counseling, 2) the optimal
screening and supplementation strategy for micronutrient
deficiencies after surgery before and during a subsequent
pregnancy, 3) the best diagnostic method for the diagnosis
of gestational diabetes mellitus, and 4) the ideal compos-
ition of breast milk from a nutritional point of view,
needed before breastfeeding can be safely advised in this
sub-population of lactating women.
Objective and aims
The overall objective of the AURORA study (bAriatric
sUrgery Registration in wOmen of Reproductive Age)
is to systematically follow women of reproductive age
(18–45 year) who will undergo bariatric surgery or who
already underwent bariatric surgery until six months after
a subsequent pregnancy.
Specific aims are:
1. To evaluate the effect of bariatric surgery in obese
women of reproductive age on body composition,
nutritional status, fertility, sexuality, contraception,
co-morbidities, medication and substance use, physical
activity, quality of life, anxiety and depression, by
comparing these parameters pre- and postoperatively.
2. To investigate pregnancy outcomes in women with
a history of bariatric surgery according to the type
of procedure (restrictive, malabsorptive, combined),
interval between surgery and conception, weight
loss after surgery, nutritional status, gestational
weight gain, sexuality, co-morbidities, medication
and substance use, physical activity, quality of life,
anxiety and depression.
3. To investigate breast milk composition in women
with a history of bariatric surgery in relation to the
maternal diet and level of physical activity.
Methods/design
Overall study design and setting
AURORA is a national multi-centric prospective cohort
study with the participation of eight centers in Belgium:
1) the University Hospital of Leuven (UZL) (=coordina-
ting center), 2) Middelheim Hospital Antwerp (MA), 3)
St-Augustinus Hospital Wilrijk (SAW), 4) St-Nikolaas
Hospital St-Niklaas (SNSN), 5) Medical Hospital of
Mons-Hainaut (CHR), 6) Ghent University Hospital
(UZG), 7) St-Jan Hospital Bruges (SJB) and 8) St-Lucas
Hospital Bruges (SLB). Figure 1 illustrates the geo-
graphical distribution of the participating centers and
provides information about the target population for
recruitment of each center.
Inclusion is possible at 4 different time points: 1) before
surgery, 2) after surgery, 3) at the beginning of pregnancy
and 4) in the immediate postpartum (day 3–4). The
bariatric surgeon and his team are responsible for the
recruitment before and after surgery. Also fertility specia-
lists and obstetricians providing preconception care assist
with the recruitment of non-pregnant women with a
history of bariatric surgery. Recruitment at the beginning
of pregnancy is done by obstetricians and midwifes at the
participating centers. Recruitment of lactating women
with previous bariatric surgery is done by the researchers/
midwifes at the maternity units.
The exact scheme of data collection depends on the time
of inclusion and is summarized in Fig. 2. A total of five
measuring moments is foreseen for a woman being re-
cruited before surgery. Four additional measuring mo-
ments are foreseen in a subsequent pregnancy and 2
measuring moments in the postpartum period. A max-
imum follow-up of 11 measuring points is aimed when
recruiting a women before surgery and following her until
a subsequent pregnant and six month postpartum period.
This equals to a follow-up duration of approximately two
and a half year. Women being recruited at the start of
pregnancy have a total of six measuring moments, which
equals to a follow-up duration of one to one and a half
year. Women who gave birth within UZ Leuven are given
the opportunity to investigate the macronutrient content
of their breast milk. A milk sample of 1.5–2 ml is collected
four days after delivery and then weekly until the routine
postpartum consultation six weeks after delivery.
Eligibility criteria
The inclusion and exclusion criteria are summarized in
Table 1 and depend on time of inclusion.
Study visits and data collection
Both clinical and self-administered data are collected
before and after surgery and in a subsequent pregnancy
and postpartum period. The clinical data are obtained by
the local research staff and afterwards directly added
in a simple, secure and user-friendly internet database
(www.aurorastudy.org/en). Participants receive a link via
email to complete the online questionnaires. The system
allows participants to log in with their email address,
ensuring safe and private access. Participants receive
reminders via email when a questionnaire is not com-
pleted within one week. Data are encoded directly in the
database and transformed to excel for future analyses.
An attempt was made to match the study measuring
moments as much as possible with the routine consul-
tations of the participating centers. The data collection
at each contact is presented in Table 2.
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Data obtained by the researchers
Anthropometric data include body height, weight and
fat percentage. The body length is measured at the first
measuring moment, using a microtoise to the nearest
0.5 cm. The body weight is measured at each clinical
measuring moment to the nearest 0.1 kg with indoor
clothing but without shoes, using the local calibrated
balance. The pre-operative weight in non-pregnant
subjects, together with the subjects’ length, is used to
calculate the pre-operative BMI (kg/m2). Pregnant
subjects were asked for their pre-pregnancy weight
(self-administered) to calculate the pre-pregnancy BMI
(kg/m2). The total gestational weight gain is defined as
the weight at time of birth minus the pre-pregnancy
weight. The body fat percentage is only measured in
non-pregnant subjects, using the local Bio-Electrical
Impedance Analysis (BIA).
The medical history of the participant is questioned
at baseline (T0), together with the type, date and location
of bariatric surgery. The medical history relates to the
subject’s previous medical conditions and diseases. The
specific type of procedure is questioned (LAGB, SG,
RYGB and BPD/DS) in order to distinguish between the
restrictive, purely malabsorptive or combined types of
procedures. The date of the surgery is used to calculate
the interval period between surgery and conception.
Follow-up by a dietitian, possible complications, co-
morbidities and the use of medication or nutritional
supplements are monitored at each pre- and postoper-
ative and pre- and postnatal follow-up consultation.
The nutritional status of each participant is assessed
by biochemical parameters in venous blood (Table 3).
This screening includes assessments which are covered
by the National Institute for Sickness and Disability
Fig. 1 Different sites. = pregnant and non-pregnant subjects. = non-pregnant subjects. = pregnant subjects
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Insurance (NISDI) as well as specific additional assess-
ments not being covered by the NISDI but covered by
study budget. The assessments covered by the NISDI
are clinically relevant in the context of an optimal fol-
low-up of the subject after bariatric surgery or during
pregnancy. The additional assessments are not included in
the standard care, but are considered being relevant as
study parameter. The serum blood samples should opti-
mally be collected in a fasting condition. The obesity clinics
are responsible for the pre- and postoperative assessments,
the obstetric units for the preconception, pre- and postnatal
assessments. The nutritional status of the newborn is
determined by biochemical parameters in venous cord
blood, collected at the delivery wards. These serum
markers are analyzed in the local hospitals, all equipped
with certified laboratories with validated ring tests.
The assessment of the fasting glucose level at the begin-
ning and 24 weeks of pregnancy is also included for the
Fig. 2 Scheme of measuring moments. = online data collection. = fasting blood sample. = bariatric surgery. = pregnancy. = birth.
= measuring moment. = breast milk samples. T1 (before surgery), T2 (3 weeks after surgery), T3 (3 months after surgery, T4 (6 months after
surgery), T5 (12 or X months after surgery), T6 (1st trimester of pregnancy), T7 (2nd trimester of pregnancy), T8 (3rd trimester of pregnancy),
T9 (birth), T10 (6 weeks postpartum), T11 (6 months postpartum)
Table 1 Inclusion and exclusion criteria according to time of inclusion
Before surgery (T1) After surgery (T2-T5) Pregnancy (T6) Breast milk composition
Inclusion criteria *women aged 18–45
*approved for
bariatric surgery
(all types of surgery)
*internet connection
and email
*women aged 18–45
*previous bariatric surgery
(all types of surgery)
*internet connection
and email
*women aged 18–45
*previous bariatric surgery
(all types of surgery)
* < 15 weeks of gestation
*internet connection
and email
*women aged 18–45
*lactating women with previous bariatric surgery
*pregnancy duration between 37 and 41 weeks
Exclusion criteria *infertility
(e.g. menopause,
hysterectomy)
*infertility
(e.g. menopause,
hysterectomy)
/ *use of medication possibly affecting breast milk
(discussed individually with neonatologist)
*problems or difficulties with breastfeeding
* > 10 % weight loss in newborn 4 days after
delivery
*diabetes or GDM
Abbreviations: GDM gestational diabetes mellitus, T time =measuring moment
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pregnant subjects as an alternative for the oral glucose
tolerance test (OGTT), which is the standard diagnostic
test for GDM [34]. It is well known that a glucose
overload in patients with a malabsorptive or mixed pro-
cedure surges insulin secretion, probably causing reactive
hypoglycemia [22]. The use of an OGTT can therefore be
contra-indicated for the diagnosis of GDM in subjects
with a history of bariatric surgery. Subjects who report to
be sensitive for severe dumping symptoms are screened
for GDM by a first and second trimester assessment of
the fasting glucose level. When the fasting glucose levels
appear to be indicative for a disturbed glucose metabo-
lism, glucose home monitoring will be initiated around
24–28 weeks of gestation. This includes fasting and two
hours postprandial glucose monitoring for seven days
using a glucose monitoring kit.
Clinical parameters of the pregnant subjects are
measured by the researcher in every pregnancy trimester
(T6-T8). These parameters include gestational age (based
on the crown-rump length assessed by fetal ultrasound),
blood pressure and proteinuria (>300 mg/24 h). The diag-
nosis of pregnancy-induced hypertension is defined
according to the guidelines of the International Society for
the Study of Hypertension in Pregnancy: de novo blood
pressure ≥ 140/90 mmHg appearing after 20 weeks of
gestation. Pre-eclampsia is defined as the presence of
pregnancy-induced hypertension or chronic hypertension
in combination with proteinuria [35]. All possible compli-
cations during pregnancy, delivery and postpartum period
are prospectively recorded in the patient’s study file. Next,
outcomes from the fetal ultrasounds are summarized
(quality of ultrasound, biparietal diameter, abdominal
circumference, femur length, head circumference, frontal
occipital diameter, estimated fetal weight, amniotic fluid
index, pulsatility index of A. Uterina, Umbilicalis and
Cerebri Media). In case of a laparoscopic adjustable gastric
band, management of the band (closing – opening) is
evaluated. The gestational age in weeks, use of combined
spinal epidural anesthesia, fetal position and mode of de-
livery (vaginal, cesarean section, instrumental delivery) are
collected at birth (T9). Characteristics from the newborn,
including birth weight and length, Apgar scores, admis-
sion to the neonatal intensive care unit and clinical prob-
lems are reported (T9). Early postpartum data include
information about breastfeeding practices (exclusive
breast feeding, artificial feeding, difficulties, duration).
Table 2 Overview of data collection
T0 T1 T2 T3 T4 T5 T6 T7 T8 T9 T10 T11
D4 W1 W2 W3 W4 W5 W6
Researcher
Anthropometrics X X X X X X X X X X X
Bariatric surgery X X X X X X
Co-morbidities & medication X X X X X X X X X X
Blood analysis X X X X X X X X
Pregnancy X X X X
Participant
Medical & obstetric history X
Demographics X
Lifestyle habits X X X X X X X
Physical activity X X X X X X X X X
Food Frequency Questionnaire X X X
3-day food record – dietary supplements X X X X X X X
Depression X X X X
Anxiety X X X X X X X
Quality of life X X X X X X
Intention of becoming pregnant Xa
Menstrual cycle, contraception, sexuality X X X
Breastfeeding X
Milk sample X X X X X X X
Abbreviations: T0 baseline, T1 before surgery, T2 3 weeks after surgery, T3 3 months after surgery, T4 6 months after surgery, T5 12 or X months after surgery,
T6 1st trimester of pregnancy, T7 2nd trimester of pregnancy, T8 3rd trimester of pregnancy, T9 birth, T10 6–8 weeks postpartum, T11 6 months postpartum,
D4 day 4 postpartum, W 1, 2, 3, 4, 5, 6 weeks postpartum
ainclusion pre- and postoperatively
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Clinical parameters being reported 6 weeks and 6 months
after delivery include body weight, the intake of dietary
supplements or medication and any clinical problems or
complications occurring.
Self-administered data by the participants
Demographic data are collected at baseline (T0). Date of
birth, nationality, ethnicity of the participant and first-
line family members, marital status, family situation,
educational level and occupational data are questioned.
The obstetric history of the participant is also collected
at baseline (T0). This includes the number of previous
pregnancies, the need for a fertility treatment, the final
outcome of a previous pregnancy (miscarriage, abortion,
ectopic pregnancy, born alive) and gestational age and
birth weight of the baby.
Participants who are included before or after surgery
are asked for their intention of becoming pregnant and
the period in which they plan to do this.
A study-specific developed questionnaire is used to
evaluate the menstrual cycle, contraceptive use and
sexual activity. The length of the menstrual cycle, the
cycles per year, pattern and duration of bleedings and
the presence of amenorrhea or oligomenorrhea are
questioned. The need for a fertility treatment and the
method of the treatment is asked. The used contracep-
tive is also of interest, including the exact type, dose
and problems with usage. The frequency of sexual
intercourse and any related problems are recorded.
These questionnaires are based on the standard clinical
assessments at the gynecology clinic of UZ Leuven.
Lifestyle is being investigated using questionnaires about
dietary intake, physical activity, alcohol, tobacco use and
sleeping habits, all collected via the online system. The
actual diet is examined on three non-consecutive days
(including one day of the weekend) by use of a 3-day
estimated dietary record, using an online semi-structured
diary. Information on the type and amount of foods
consumed is collected through an open entry format. Each
day of the food record was divided into breakfast, lunch,
dinner and morning, afternoon and late-evening snacks.
Subjects who donate breast milk samples are additionally
asked to complete a Food Frequency Questionnaire (FFQ)
in the immediate postpartum (day 3–4) and 6 weeks
postpartum. This FFQ is inspired on pre-existing FFQ’s
already used in the Belgian population groups (e.g. [36])
and on the general accepted FFQ development guidelines
[37]. The FFQ allows to monitor trends in nutrient intake
and dietary pattern (=usual intake). The level of physical
activity is measured using a Dutch and French version of
the Kaiser Physical Activity Survey (KPAS). This survey
measures different domains of physical activity including
1) household and family care, 2) professional activities, 3)
daily life activities and 4) sports and exercise. The KPAS is
Table 3 Nutritional assessment
Standard assessment
(covered by NISDI/RIZIV)
Additional study assessment
(not covered by NISDI – study budget)
Obesity clinic *haematology (haemoglobin, haematocrit and red blood cell
count: mean corpuscular haemoglobin, mean corpuscular
volume, mean corpuscular haemoglobin concentration)
*coagulation (prothrombin time, activated partial
thromboplastin time)
*total protein, albumin
*vitamin B-12, folate serum
*25-hydroxy vitamin D
*iron, transferrin, tranferrin saturation, ferritin
*calcium, zinc
*glucose metabolism (glucose)
*folate red blood cells
*vitamin A, E, B-1, magnesium
Obstetrics and
gynaecology
*haematology (haemoglobin, haematocrit and red blood cell
count: mean corpuscular haemoglobin, mean corpuscular
volume, mean corpuscular haemoglobin concentration)
*coagulation (prothrombin time, activated partial
thromboplastin time)
*total protein, albumin
*vitamin B-12, folate serum and red blood cells
*iron, transferrin, tranferrin saturation, ferritin
*calcium, zinc, magnesium
*glucose metabolism (glucose)
*coagulation factors, vitamin K1
*vitamin A, vitamin E, vitamin B-1
*25-hydroxy vitamin D
Veneus cord blood *haematology (haemoglobin, haematocrit and red blood
cell count: mean corpuscular haemoglobin, mean corpuscular
volume, mean corpuscular haemoglobin concentration)
*coagulation (prothrombin time, activated partial
thromboplastin time, vitamin K1)
*vitamin B-12 and folate serum and red blood cells
*vitamin A and 25-hydroxy vitamin D
Abbreviations: NISDI/RIZIV National Institute for Health and Disability Insurance/Rijksinstituut voor Ziekte- en Invaliditeitsverzekering
Jans et al. BMC Pregnancy and Childbirth  (2016) 16:195 Page 7 of 11
validated for both pregnant and non-pregnant women
[38, 39]. A Dutch and French version of the Alcohol
Abuse Disorder Identification Test (AUDIT-C) includes
three short questions on alcohol use and is considered to
be a practical and validated screening test to detect alco-
hol abuse and dependency [40]. Smoking is questioned,
and for smokers the amount of cigarettes or other tobacco
products per day is recorded. Finally, sleep duration
during the week and week-end is questioned.
The intake of dietary supplements is also questioned
via an online questionnaire (brand name, dosage, poso-
logy, start and end date).
The quality of life is determined using the Moorehead-
Ardelt Quality of Life Questionnaire II (M-A QoLQII)
[41]. This validated questionnaire is part of the Bariatric
Analysis and Reporting Outcome System (BAROS) [42].
BAROS is a scoring system to evaluate quality of life
(M-A QoLQII), weight loss and improvement of co-
morbidities. The M-A-QoLQII is translated in Dutch by
two experts [43] and in French by the research team.
Evaluation of psychosocial health focuses on anxiety and
depression. A Dutch validated and a French non-validated
version of the American State-Trait Anxiety Inventory
evaluates the two concepts of ‘state and trait anxiety’ [44].
Two separate questionnaires include 20 items or statements
on which answers can be given on an intensity (state
anxiety) or frequency (trait anxiety) scale. A Dutch and
French version of the Edinburgh Depression Scale (EDS), a
validated 10-item scale, is used to measure depressive
feelings during the pre- and postnatal period [45–47].
Finally, a structured Dutch questionnaire developed by
Guelinckx et al. (2011), also translated into French by
the researchers, is used six months after birth (T11) to
evaluate the intention, initiation and duration of breast-
feeding and reasons to quit breastfeeding.
Analysis of the breast milk macronutrient composition
Human milk samples of 1.5 to 2 ml are collected from
subjects who gave birth at UZ Leuven. A first sample is
being collected at day 4 after delivery at the maternity
units. Samples are collected manually or by use of a pump
three minutes after the baby starts suckling on the breast.
Samples are stored at−20 °C [48]. Subjects receive instruc-
tions by the researchers on how to collect a weekly sample
by themselves at home until the routine consultation six
weeks after delivery. They receive sterile recipients to
collect the samples and a thermometer to measure the
temperature of their own freezers. All samples are gathered
at the research center when all samples are collected six
weeks after birth.
The human milk macronutrient (fat, carbohydrate,
protein) and energy content is easily assessed by use of
the MIRIS® Human Milk Analyzer. This is a relatively
small device that is based on infrared spectroscopy, and
requires very limited amounts of milk (1.5 to 2 ml) [49].
The iCheck™ Fluoro (BioAnalyt, Germany) is used for
the analysis of the vitamin A content in breast milk.
This is also a small and user-friendly device that is vali-
dated against High-Performance Liquid Chromatography
(HPLC) which is the reference method for vitamin A ana-
lysis in breast milk [50].
Type of analyses
The study design allows different types of analytical proce-
dures, including descriptive analyses, cohort study analyses
and even case–control study analyses as our study team is
also focusing on obese (pregnant) women in other projects.
Analyses will be performed using SPSS software and a
specific P-value of significance will be determined based on
the number of test that will be performed for a specific
research question. The normality of continuous variables
will be checked with normality tests (Kolmogorov-Smirnov
or Shapiro Wilk’s test). Depending on the normality
outcomes, parametric (Student-t, one-way AN(C)OVA, r-
epeated measures AN(C)OVA, Chi2, Pearson, multiple and
logistic regression test) or non-parametric (Mann–Whitney
U, Kruskall Wallis, Spearman and Friedman tests) tests will
be used. Interaction, group (different types of surgery,
pregnant ≤ or > one year following surgery, bariatric surgery
versus obese and normal weight controls, …) and time
(before surgery versus 6 and 12 months after surgery,
before pregnancy versus different pregnancy trimesters,
pre- versus postnatal, …) effects will be comprehensively
examined. A biostatician will be consulted to assist with the
statistical analyses.
Power calculation
No power calculation has been performed for the
prospective cohort study because of the many potential
outcome measures with varying incidence numbers. The
aim is to include as many women as possible, starting
pre- or postoperatively and in a subsequent pregnancy
We intend to expand the group of non-pregnant women
to at least 300 women at the end of 2016 and the group
of women being included at the start of pregnancy to a
total of 150 women. This appears to be realistic based
on the current clinical experience.
A power calculation was performed for the breast milk
macronutrient analyses. Based on the study of Marin et
al. (2005) [51], it was calculated how many subjects are
needed in a group of lactating women with a history of
bariatric surgery and in obese, overweight and normal
weight controls. A difference of 10 g/L in fat content
between normal and obese mothers and a standard
deviation of 9.4 g/L, together with a sample size power
of 90 %, were used for the sample size calculation. When
taking into consideration a 30 % drop-out rate, a total of
72 women (24 in each group) is needed.
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Start of the study and expected results
Recruitment of the first participant took place in December
2012. First research papers on various topics within this
study are expected to be published in 2016.
Discussion
According to the authors’ knowledge, AURORA is the
first prospective cohort study which starts to include
women undergoing a bariatric procedure until a subse-
quent pregnancy and postpartum period. Its strength is
the long duration of follow-up and the unique collabo-
ration between obesity and obstetric units. A large
number of females who underwent bariatric surgery, both
pregnant and non-pregnant, can be achieved as a result of
the multi-center approach. The online secured database
allows easy gathering of clinical data obtained by the
researchers across the different research sites, and
provides an easy manner of data collection from partici-
pants. The online system is also accompanied with limita-
tions. The more non-directive approach of participants
might probably lead to a higher rate of missing values
when comparing to the standard approach of distributing
paper questionnaires personally to the subjects, and to a
relatively large drop-out rate during follow-up. This rate is
currently estimated around 15 %. Since this study relies
on online data gathering, a temporary failure of the system
could mean a temporary shutdown of data collection. For
this reason, paper case report forms (CRFs) were designed
and spread across the different research sites. Local
researchers and their staff are asked to complete a CRF
for each visit of a patient which equals to a measuring mo-
ment in order to serve as back-up. For participants, this
would imply temporary inconvenience and data loss.
The greatest challenge is to obtain the complete follow-
up of patients being recruited before surgery until a subse-
quent pregnancy. Official organizations recommend to
postpone pregnancy until 12 to 18 months after surgery to
avoid the phase of rapid weight loss [6]. When taking into
consideration the minimal time interval between surgery
and conception of 12 months, and assuming there are less
to none fertility problems, a total follow-up will take about
two and a half year. Participants are reminded every six
months of possible continuation of the study when they
should become pregnant. So far, this seems to be sufficient
in order to ensure that no pregnancies are missed among
women being recruited before or after surgery. It is esti-
mated that about 12 000 bariatric procedures are being
performed per year in Belgium [8]. If we assume that
Belgium follows to international trends of growing num-
bers of female adolescents attending for bariatric surgery
and the majority of bariatric patients being premenopausal
women (about 70 %) [12, 13], we can assume that 300 is a
realistic number We aim to include sufficient lactating
subjects with a history of bariatric surgery. It is
demonstrated that obese women are less likely to initiate
and continue with breastfeeding [5], and so far, no breast-
feeding rates are known of lactating women with previous
bariatric surgery. Depending on the number of inclusions
so far, recruitment of lactating women with previous bariat-
ric surgery has additionally started in other local obstetric
centers within AURORA (UZG and SAW). Efforts to mo-
tivate and stimulate participants to collect breast milk sam-
ples are made by weekly text messages, emails or phone
calls, depending on the participant’s preference.
Another discussion point relates to the local devices
used for anthropometric measurements. The fact that
the local scales and bio-impedance devices are used,
might lead to a certain degree of bias. This remark also
relates to the nutritional biochemical assessments. Serum
markers are analyzed in the local hospitals, all with certi-
fied laboratories with validated ring tests. Nevertheless,
small differences in analyses, especially for the more com-
plex assessments of fat-soluble vitamins and coagulation
markers, may implicate small differences in outcome
values. Finally, no specific actions are undertaken to
include women from all socio-economic backgrounds.
This may lead to the inclusion of more women with a
specific income and educational level, which in turn might
lead to less generalization of the outcomes for follow-up
and lifestyle.
The AURORA study also has strong potential to clarify
the combined impact of bariatric surgery and a subse-
quent pregnancy on maternal, fetal and neonatal health.
The study comprises a combination of many medical and
personal data of pregnant and non-pregnant women with
bariatric surgery. The study includes regular and intensive
monitoring of nutritional biochemical parameters, com-
bined in pregnancy with the assessment of fetal growth by
ultrasound, the monitoring of maternal weight, the dietary
assessment (of dietary intake) and intake of dietary supple-
ments. Prevalence and incidence number of nutritional
deficiencies, surgical complications and more uncommon
outcomes such as birth defects can be evaluated within
this cohort.
The findings from the AURORA study are believed to
generate a significant public health impact. Outcomes
obtained from this study will be translated into clinical
guidelines and recommendations for the reproductive
management of women undergoing bariatric surgery and
subsequently becoming pregnant.
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